AbbVie Inc to participate at the UBS Global Health Care Conference
AbbVie will participate in the UBS Global Healthcare Conference on Monday, May 23, 2016. Bill...
Mylan Launches Generic Frova Tablets for for migraine headaches in adults.
Mylan N.V. announced the U.S. launch of Frovatriptan Succinate Tablets 2.5 mg, a generic version...
Johnson & Johnson opens first international JLABs site in Canada
Johnson & Johnson Innovation LLC announced the opening of JLABS @ Toronto, a new 40,000-square-foot...
Pfizer awards more than $1 million to fund metastatic breast cancer research
Pfizer Inc announced that it has awarded a total of more than $1 million in...
Johnson & Johnson opens first international JLABs site in Canada
Johnson & Johnson Innovation LLC announced the opening of JLABS @ Toronto, a new 40,000-square-foot...
Empliciti (elotuzumab) for the Treatment of Multiple myeloma treatment from Bristol-Myers Squibb and AbbVie...
First and only immunostimulatory antibody approved in the European Union for multiple myeloma...
EC approves Immuno-Oncology Combination, Bristol-Myers Squibbs Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen, for...
Opdivo + Yervoy Regimen now approved for unresectable or metastatic melanoma patients, regardless...
Merck Expands Popular Line of Guava® Flow Cytometers
Optical configurations meet needs of any lab, research discipline or individual application Product can...
Merck Showcases New Innovations at Analytica 2016
Merck, a leading science and technology company, will exhibit a new range of products and...
Baxter to Present at the 2016 UBS Global Healthcare Conference
Baxter International Inc will present at the 2016 UBS Global Healthcare Conference on Monday, May...
